skip to content

Department of Pathology

 
Read more at: The Chris Abell Postdoc Business Plan Competition

The Chris Abell Postdoc Business Plan Competition

26 March 2021

Do you have an idea worth a £20k investment? Our Postdoc Business Plan Competition has become a key annual event in the University’s entrepreneurial ecosystem and has spawned a number of successful spin-out companies. In 2020 the competition was renamed to honour the life and career of the late Chris Abell, Pro-Vice-...


Read more at: Tackling COVID-19: Professor Ian Goodfellow

Tackling COVID-19: Professor Ian Goodfellow

4 May 2020

Ian Goodfellow is no stranger to infectious disease outbreaks. In 2014 he left behind the safety of his Cambridge lab to join a taskforce fighting the hazardous Ebola outbreak in Sierra Leone. With COVID-19 now sweeping the globe, Goodfellow is once again applying his scientific expertise to finding solutions in real time...


Read more at: Dr Ian Brierley comments on measures to needed for when Football resumes

Dr Ian Brierley comments on measures to needed for when Football resumes

4 May 2020

Dr Ian Brierley, explained exactly why spitting and other practices were dangerous, adding, "If the person is infected but asymptomatic, or infected and symptomatic, the virus is present in the throat, and can be ejected into the environment by spitting. "Players may have to develop new celebrations so that they are not in...


Read more at: Prof Ming Du one of a group of scientists to lead a new study to identify people with the most aggressive types of lymphoma who are less likely to respond to standard drugs.

Prof Ming Du one of a group of scientists to lead a new study to identify people with the most aggressive types of lymphoma who are less likely to respond to standard drugs.

4 December 2018

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy Bloodwise: New tool to find and fight most dangerous types of lymphoma


Read more at: Suzanne Turner discusses breast-implant-associated blood cancers in the Daily Mail

Suzanne Turner discusses breast-implant-associated blood cancers in the Daily Mail

23 January 2018

http://www.dailymail.co.uk/health/article-5300269/Mothers-breast-implants-triggered-rare-blood-cancer.html


Read more at: Academic Promotions

Academic Promotions

22 November 2017

Congratulations to Suzanne Turner and Ian Brierley on having been promoted to Reader and Professor respectively.


Read more at: Professor Klaus Okkenhaug will join the Department of Pathology from 1 October 2017 as its new Professor of Immunology

Professor Klaus Okkenhaug will join the Department of Pathology from 1 October 2017 as its new Professor of Immunology

13 February 2017

Professor Klaus Okkenhaug will join the Department of Pathology from 1 October 2017 as its new Professor of Immunology. Klaus Okkenhaug obtained his B.Sc. in Biochemistry from the University of Victoria, British Columbia, Canada, followed by a Ph.D. in Immunology from the University of Toronto, where he studied CD28...


Read more at: Dr Dora Pereira interviewed by the BBC

Dr Dora Pereira interviewed by the BBC

7 February 2017

Dr Dora Pereira has been interviewed by the BBC's Health Check programme, focusing on treating anaemia. The interview is available at minute 16:45 : http://www.bbc.co.uk/programmes/p04rhc27


Read more at: BBC 5 Live broadcast from the Division of Virology

BBC 5 Live broadcast from the Division of Virology

23 June 2016

BBC 5 live Daily was broadcast from the Division of Virology on Tuesday 14 June. The programme can be listened to on iPlayer until July 13: http://www.bbc.co.uk/programmes/b07fdtd5 Adrian Chiles interviewed Rupert Beale, Gillian Fraser, Ian Goodfellow and Suzanne Turner (during the final hour).


Read more at: Professor Nick Coleman and Dr Matthew Murray have developed a new blood test that could diagnose childhood cancer more accurately

Professor Nick Coleman and Dr Matthew Murray have developed a new blood test that could diagnose childhood cancer more accurately

16 December 2015

Nick Coleman and Matthew Murray have developed a non-invasive, low-cost blood test that could help doctors diagnose some types of malignant childhood tumour. Read more here .